共 21 条
[1]
Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), 2015, RIESG CARD DOS ALT I
[2]
ArtRoCad: health resources utilization and socioeconomic impact of knee and hip osteoarthritis. I. Methods and population characteristics
[J].
REUMATOLOGIA CLINICA,
2006, 2 (05)
:224-234
[7]
FDA Drug Safety Communication, 2015, DRUG SAF COMM FDA ST
[9]
Symptomatic Effects of Chondroitin 4 and Chondroitin 6 Sulfate on Hand Osteoarthritis A Randomized, Double-Blind, Placebo-Controlled Clinical Trial at a Single Center
[J].
ARTHRITIS AND RHEUMATISM,
2011, 63 (11)
:3383-3391